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Hydrogen peroxide,  a  secretory product of mononuclear phagocytes (1), accounts 
for a  considerable portion of their nonphagocytic lysis of tumor cells in at least  three 
circumstances: when certain secretagogues are added (2-4), when antitumor antibody 
is  present  (5,  6),  or  when  the  tumor  cells  are  coated  with  eosinophil  peroxidase. 1 
Granulocytes also secrete H202, which may participate  in their cytotoxic effects in a 
variety of situations (7-13). Finally, preformed or enzymatically generated H202, with 
or without a  peroxidase, lyses tumor cells (2,  14-19). 
In  the  present  study  we  sought  to  devise  a  nontoxic  way  to  deliver  hydrogen 
peroxide  to sites  of malignancy  in  vivo and  to  test  its  antitumor  efficacy.  Glucose 
oxidase was chosen for this  purpose  because  its substrates,  glucose and  oxygen, are 
abundant  in  the  body fluids,  because  its  sole products are  H202 and  gluconic acid 
(20),  and because a  flux of H~O2 generated enzymatically in situ  might be less toxic 
than  injection of preformed  H202.  To prolong the retention  of the H~O2-generating 
system  at  the  site  of administration,  glucose  oxidase  was  coupled  covalently  to 
polystyrene microspheres. 
Below are described the distribution  of parenterally  injected glucose oxidase-latex 
particles  (GOL),  2 their  antitumor  effect  in  the  peritoneal  cavity and  subcutaneous 
tissues of the mouse, the role of supplemental oxygen, the synergy between GOL and 
another antitumor agent capable of inhibiting a major peroxide-catabolizing pathway 
in tumor cells, and the relative lack of toxicity of this novel treatment. 
Materials  and Methods 
Coupling of Enzymes to Polystyrene Microspheres.  Carboxylated latex particles were obtained as 
a  10% suspension from Dow Chemical Co., Indianapolis, Ind. The manufacturer reported their 
diameter as 0.907 :l: 0.0061  /~m (mean +  SD).  13.2 ml of latex suspension was washed three 
times by centrifugation at 15,000 g for 15 min at 4°C in 30 ml 0.2 M sodium acetate buffer, pH 
5.4.  The pellet  was resuspended  in 44 ml of the buffer and  mixed with  26.1 ml of glucose 
oxidase  (fl-D-glucose:oxygen  1-oxidoreductase,  E.C.  1.1.3.4,  type  V,  from  Aspergillus  niger), 
representing  ~160  mg of protein  with  an  activity of 1,050-1,400  Sigma  units/ml  (Sigma 
Chemical Co., St.  Louis, Mo.), or with the same volume of catalase from beef liver,  catalog 
number C 100 from Sigma Chemical Co., representing about 886 mg of protein with an activity 
of 1.17 ×  106 Sigma units/ml  (one Sigma unit of glucose oxidase catalyzes the oxidation of 1 
#mole of ~-D-glucose/min at 35°C in air-saturated buffer, pH 5.1; one Sigma unit ofcatalase 
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degrades  1 ~mole of H202/min at  25°C in 0.05  M  phosphate buffer, pH  7.0). Immediately 
before use, 1-cyclohexyl-3-(2-morpholinoethyl)carbodiimide-metho-p-toluenesulfonate  (Aldrich 
Chemical Co., Milwaukee, Wis., or Sigma Chemical Co.) was dissolved in the acetate buffer at 
a concentration of 254 mg/ml, and 17.6 ml was added to the latex-enzyme suspension, which 
was then stirred for 30 rain at 4°C. After centrifugation, the pellet was resuspended in 44 ml of 
1 M glycine (Fisher Scientific Co., Fair Lawn, N. J.), and the suspension was stirred for 30 min 
at room temperature. The latex was then washed four times by centrifugation in 30 ml of 0.9% 
NaCI and resuspended in 21  ml of 0.9% NaCl. Where indicated, the beads were boiled for 20 
min to inactivate the enzyme. 
Tests of Enzyme-coupled Beads.  H202  production by  GOL  was  measured  by  the  loss of 
fluorescence  due to oxidation of scopoletin in the presence of horseradish peroxidase at 37°C, 
as described (1). The buffer (Krebs-Ringer phosphate) (1) was equilibrated with air, contained 
5.5 mM glucose, and had a pH of 7.35-7.40.  The Km of GOL for glucose was determined by 
measuring the initial rate of H202 production (V) at various concentrations of glucose  (S) and 
plotting V/S vs. V (Kin for glucose =  16.7 mM; correlation coefficient =  0.95). The Kr, of GOL 
for  02  was  estimated  in  an  oxygen  polarograph  (Yellow  Springs Instrument Co.,  Yellow 
Springs, Ohio)  using Krebs-Ringer phosphate buffer with  100  mM glucose  at  37°C in the 
presence of 1,744 Sigma units/ml of catalase. Under these conditions, H202 production was 
assumed to be twice  the observed oxygen consumption. The curve of H202 produced (y)  vs. 
time (x)  fit  the function, y  =  a  +  b In (x), with a  correlation coefficient of 0.99.  The first 
derivative of this function was used to determine instantaneous rates of H202 formation (I  0  at 
given 02 concentrations (S). A plot of V/S vs. Vindicated a Km for 02 of 0.01 mM (correlation 
coefficient  =  0.94). The activity of catalase-latex was measured by determining the number of 
beads that reduced by 50% the rate of H202 generation (1.3 nmol/min) by glucose oxidase and 
was compared with the volume of native catalase solution necessary to achieve the same result. 
The specific activity of the catalase-latex was 7.5% of that of the initial enzyme preparation. 
The number of latex beads per milliliter was determined in a hemocytometer with a ×40 water 
immersion objective with phase contrast. The protein content of the native and bound enzyme 
preparations was measured by the method of Lowry et al. (21) with a bovine serum albumin 
standard. The sterility of the final latex suspensions was assessed by streaking 0.01-ml aliquots 
on two to four tryptic soy broth agar plates with or without sheep's blood. 
Treatment of Mice. (BALB/c ×  DBA/2)Fx (CD2F1) female mice were obtained from Simonsen 
Laboratories, Gilroy, Calif., or from Charles River Breeding Laboratories, Wilmington, Mass. 
and entered into experiments at  7-14 wk of age.  In several  experiments DBA/2 mice (The 
Jackson  Laboratory,  Bar  Harbor,  Maine)  or  (DBA/2  ×  BALB/c)F1  (D2CFx)  mice  from 
Trudeau Institute, Saranac L/~ke, N. Y. were used. In a given experiment, all mice were of one 
strain, chosen randomly from a single shipment from one supplier, and were within 1 wk of 
each other in age.  P388  lymphoma and P815  mastocytoma were  maintained by passage of 
ascites  (19). For experiments, the cells  were washed by centrifugation in Eagle's minimum 
essential medium  (MEM),  alpha  variant, containing 100  U/ml  penicillin and  100  #g/ml 
streptomycin (Flow  Laboratories, Inc., Walkersville, Md.)  and counted in a  hemocytometer. 
The desired number of cells in 0.5-1.0 ml of MEM was injected intraperitoneally (i.p.). GOL 
or an equivalent volume of 0.9% NaC1 was then given through a separate i.p. injection. 
For experiments involving  1,3-bis(2-chloroethyl)-  1-nitrosourea (BCNU) (Bristol Laboratories, 
Syracuse, N. Y.), the mean weight of the mice was used to calculate a dose of 30 mg/kg. Sterile 
BCNU was dissolved in absolute ethanol and diluted in MEM so that the desired amount was 
injected i.p.  in 0.5 ml, with a  final ethanol concentration of 2%. Controls received 0.5  ml of 
MEM-2% ethanol. 
Some of the mice were exposed  for 2-3.5 h to  100% oxygen saturated with water at  1 atm 
pressure by placing them in a gas-tight lucite chamber into which 02 (Matheson Gas Products, 
East Rutherford, N. J.) was passed after bubbling through water. Gas exited through a water 
seal, in which the 02 tension exceeded 500 mm Hg when the chamber was fully occupied. The 
chamber  temperature  was  maintained at  24.0°-25.5°C  by  a  water jacket  connected to  a 
circulating temperature regulator. 
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phosphate buffer without glucose and injected through a 26-gauge needle under the abdominal 
skin in a volume of 0.1 ml. 
Where indicated, 30% hydrogen peroxide (analytical grade, Mallinckrodt, Inc., Paris, Ky.) 
was assayed by the scopoletin method, diluted  in 0.9% NaCI, and  injected  i.p.  Ethylhydro- 
peroxide and cumenehydroperoxide were from Polysciences, Inc., Warrington, Pa. 
Other Tests. 15 min after i.p. injection of BCNU into mice bearing advanced P815 ascites,  the 
tumor cells were collected, washed three times at 4°C in Dulbecco's phosphate-buffered saline 
(Grand Island Biological Co., Grand Island, N. Y.), and assayed for glutathione reductase as 
described  (19). Serum levels of glucose,  urea nitrogen, creatinine, bilirubin,  glutamic-pyruvic 
transaminase,  and creatine phosphokinase were measured in the clinical laboratories of The 
New  York  Hospital  by  standard  methods.  The  erythroeyte count  was  determined  with  a 
hemocytometer. 
Estimation  of the  Percent Killing  of P388.  In three  separate  experiments,  survival  time  was 
determined for groups of mice (5-33 per group) injected i.p. with P388 cells ranging in number 
over three to seven orders of magnitude.  Survival  in days (x)  was plotted against  log10 cells 
injected  (y), and the best fit  of the data determined to the equation, y  =  ax  +  b, by linear 
regression.  The following assumptions were made: that all dividing tumor cells gave rise to two 
daughters, each of which divided; that generation time was constant until death of the host; 
and that all hosts died when a fixed number of P388 cells was attained. Then, doubling time 
of the tumor cells in hours =  t~ =  240og 2)/(-a). Using the mean td from the three experiments 
(14.28 +  1.94 h), the percent tumor cell kill in a given experiment with GOL was estimated as 
100(1 -  [2~n/~]-1),  where n ffi days of increased survival compared with controls. 
Results 
Characteristics  of GOL.  The properties of nine consecutive preparations of GOL are 
summarized in Table I. The average GOL suspension contained 5.8 X  101° beads/ml. 
In  air-saturated  buffer  at  pH  7.4  with  5.5  mM  glucose,  1  ml  of beads  typically 
produced  172  nmol  H202/min  (range,  99-315).  99-100%  of this  activity was  sedi- 
mentable in a microfuge or retained by a filter (0.22/~m pore size) and thus appeared 
to be bound to the beads. On the average,  1.4% of the added protein was coupled to 
the beads; their specific activity was  17% of that of the initial enzyme preparation. 
Fate of GOL after i.p.  Injection.  Between 4  and 8 h  after injection, most of the fluid 
of the GOL suspension was cleared from the peritoneal cavity, leaving from 10 to 100 
tightly packed macroscopic aggregates of latex particles along the anterior peritoneal 
lining and the mesentery, in the peripancreatic fat, against the serosal surfaces of the 
stomach and spleen, between the lobes of the liver, and along the inferior surfaces of 
the  diaphragms.  By  13  h,  peritoneal  lavage  recovered  only 0.045%  of the  injected 
GOL  as  free  particles,  with  an  enzymatic  activity  ~50%  of that  of an  equivalent 
number of uninjected particles.  Also recovered were 4  ×  10  e leukocytes, 75% neutro- 
philic, each containing ~20 GOL particles with activity ~ 10% of that of an equivalent 
number of uninjected beads.  The GOL aggregates contained rare mononuclear cells 
at 4 h  and were then gradually infiltrated with small numbers of polymorphonuclear 
TABLE  I 
Characteristics of Nine Consecutive Lots of GOL 
Characteristic  Mean + SEM  Range 
Particles per milliliter 
H202, nmol/min. 109 GOL 
Soluble enzymatic activity, % of total 
Specific activity relative to native enzyme, % 
Microbial cultures 
5.8 ×  10  l° + 1.1 X 10  j°  1.3 ×  101°-1.1 X 1011 
3.6 -t- 0.9  1.0-9.6 
0.3 + 0.2  0.0-1.3 
17.0 + 3.8  2.2-37.1 
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leukocytes  through  the  second  day.  At  that  time,  the  vast  majority  of particles 
remained extracellular. However, by day  7,  the aggregates were heavily infiltrated 
with mononuclear phagocytes, which engulfed almost all the particles. These inflam- 
matory changes were limited  to the  aggregates  of GOL themselves. There was  no 
gross  or  histologic  evidence  of GOL  particles  or  inflammation  elsewhere  in  the 
peritoneal cavity or in the following organs: brain, eyes, salivary glands, submandib- 
ular  lymph  nodes,  lungs,  thymus,  heart,  diaphragms,  stomach,  duodenum,  small 
bowel,  colon,  liver,  spleen,  mesenteric  nodes,  pancreas,  kidneys,  adrenals,  uterus, 
ovaries, skeletal muscles, bones, or marrow. At 5 and  10 mo after injection of GOL, 
the histologic picture was essentially the same as on day 7, except for the appearance 
of GOL in rare Kupffer's cells by 10 mo. 
Prolongation of Survival after i.p. Injection of GOL and 106 P388 Lymphoma Cells.  To 
quantify antitumor activity of GOL, we used the  P388 lymphoma, because of the 
highly regular relation between the number of tumor cells injected i.p. and the time 
to death of the mice. For example, in the experiment shown in Fig.  1, survival time 
was  a  linear  function  (r  =  0.98)  of the  logarithm  of the  number  of cells  in  the 
inoculum, over all seven orders of magnitude tested. Injection of 100 or more P388 
cells killed  100% of the mice. Putative injection of 10 cells killed 40% of the mice. 
Putative injection of 1 cell killed 20% of the mice (five mice per group). 
When 106 P388 cells were injected i.p., followed by 1 ml ofGOL i.p., the mice lived 
an average of 3.2 d  (27%)  longer than those receiving tumor cells and saline. These 
results were observed in eight experiments, each with a different preparation of GOL. 
This  prolongation  of survival  was  consistent  with  the  destruction  by GOL  of an 
average of 97.6% of the tumor cell inoculum (Table II). 
Enzymatic activity of the beads appeared to be necessary, because the injection of 
boiled beads did not prolong survival (Table II). Such beads produced H202 at a rate 
averaging 0.3% of that seen with unboiled GOL. 
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FIG.  1.  Survival of CD2F1 mice injected i.p. with various numbers ofP388 lymphoma cells. Means 
±  SEM for groups of five, except at doses of 6 ×  104 cells (33 mice) and  10 cells (data shown for two 
mice that died out of five injected). Correlation coefficient =  0.98, CARL F.  NATHAN AND ZANVIL A. COHN 
TABLE II 






Days survival (mean -+ SEM) 




1  4  12,5 -+ 0.9 
2  7  11,9 + 0.7 
3  7  11.4 -+ 0.7 
4  6  11.5 -+ 0.2 
5  1  12 
6  1  12 
7  4  10.5 -+ O.7 
8  5  13.0 -+ 0.6 
Overall  mean  -4-  11.9 -+ 0.3 
SEM 
12.0 +  0.0 
12.0 
11.3+0.3  15.5-+0.3 
10.9 -+ 0.7  14.0 -+ 0.3 
13.3 -+ 0.6 
15.7 -+ 0.6 
16 
17 
12.5 -+ 0.7 
17.0 +  3.4 










* 1 ml 0.9% NaCI i.p. 
1 ml saline i.p., containing 5 Sigma units of soluble glucose oxidase. 
§ 1 ml boiled GOL i.p. 
I[ 1 ml GOL i.p. 
¶ See Materials and Methods. 
Furthermore,  coupling  of  glucose  oxidase  to  the  beads  was  required,  because 
administration  of soluble glucose oxidase with an enzymatic activity equivalent  to 3 
ml of GOL afforded no increase  in survival  (Table  II). The dose of soluble  glucose 
oxidase tested in this experiment  corresponded to the dose lethal to  10% of the mice, 
as determined  in preliminary experiments,  and was 65% of the dose lethal to 50% of 
the mice. Thus, it was the highest dose of soluble glucose oxidase that could be tested 
for therapeutic benefit. 
In contrast,  the use of no more than  1 ml of GOL per mouse was dictated  by its 
cost, not by toxicity  (see below).  In two experiments,  0.3 or 0.1  ml of GOL did  not 
prolong survival after injection of 106 P388 cells (not shown). 
Effect  of Interval between  Injection  of GOL  and P388.  The tight  packing of GOL  in 
aggregates -3  h  after  its  injection  presumably restricted  diffusion of substrates  and 
products.  To  estimate  the  duration  of effective enzymatic  activity  of GOL  and  to 
evaluate the role of inflammatory cells, GOL was injected 20, 6, 3,  1, and 0  h  before 
106 P388 cells. GOL was effective if injected 0 or  1 h  before P388, but not if injected 
3-20 h  before. In contrast, the modest number of inflammatory cells detected  in the 
peritoneal  washings  peaked  at  the  latter  times,  when  an  antitumor  effect  was  no 
longer evident  (Fig.  2). This suggested that GOL exerted  its effect over the  first  few 
hours by a  mechanism independent of newly arriving inflammatory cells. 
Effect of Supplemental Substrates.  In vivo, the concentrations of oxygen and glucose 
are probably suboptimal for glucose oxidase (20, 22-26). Table III shows the effect of 
exposing mice to 100% 02 at  1 atm for 2-3.5 h  after injection of 106 P388 cells and  1 
ml GOL i.p.  In five experiments,  survival was prolonged an average of 4.7 d  (42%), 
consistent  with  destruction  of 99.6%  of the  tumor cell  inoculum.  Supplemental  02 
had no effect on the survival of mice given P388 without GOL (cf. Tables II and III). 
Supplemental  glucose in various amounts up to 0.36 mmol per mouse (presumably 
enough to triple the blood glucose concentration) did not prolong survival from P388 
lymphoma, when injected alone, with GOL, or with GOL plus supplemental  02 (not 
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FIG.  2.  Rate of loss of protective effect of GOL after i.p. injection, compared with accumulation 
of inflammatory cells. Five mice per group received  1 ml GOL i.p., and after the indicated intervals, 
a subsequent injection of 106 P388 cells. Their survival was compared to that of mice receiving  1 ml 
0.9%  NaCI  i.p.  followed  immediately  by  P388  cells  (11.2  +  0.4  d).  The  peritoneal  cavity  of an 
additional  mouse was washed out with MEM before injection of GOL or 3 or 20 h  after injection, 
and  the  total  number  of  cells,  differential  count,  and  percent  peroxidase-positive  cells  were 
determined.  The total  number per mouse of polymorphonuclear leukocytes or peroxidase-positive 
cells recovered  (whichever was larger) is indicated on a  logarithmic scale. 
Dependence of the Antitumor Effect on He 02.  Reversal of the antitumor effect of GOL 
by boiling the beads  indicated  a  need for enzymatic  activity  (Table II)  but did not 
identify which of the three enzymatic effects of glucose oxidase was most important: 
production of H202, production of gluconic acid, or consumption of glucose. To make 
this distinction, mice  were  injected simultaneously with  P388,  with GOL,  and with 
latex  beads  to which catalase  had been covalently coupled,  and then given  supple- 
mental Oz for 2 h. As shown in Table IV, catalase-latex  alone had no effect  on the 
survival  of the mice.  GOL prolonged their survival  by 4.8  d, consistent with killing 
99.6%  of the P388  cells.  Catalase-latex  abolished  the effect  of GOL.  Since catalase 
TABLE  III 
Survival of Mice Injected with 106 P388 Cells i.p.  with or without GOL followed by 
2-3.5-h Exposure  to 100% Oe 
Number of  Days survival (mean ±  SEM)  Estimated per- 
cent tumor cell 
Experiment  mice/group  Saline*  GOL~  kill§ 
1  3  11.3 ----- 0.3  l 7.0 ----- 0.6  99.9 
2  2  10.5  +  0.5  15.0  +  0.0  99.5 
3  4  10.5 ±  0.6  16.0  +  1.1  99.8 
4  5  13.2  +  1.0  16.2  +- 0.5  97.0 
5  5  10.6  ±  0.5  15.4  +  2.0  99.6 
Overall mean ±  SEM  11.2  ±  0.5  15.9  +  0.3  99.6 
*  1 ml 0.9% NaCI i.p. 
1 ml GOL i.p. 
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TABLE  IV 
Abrogation  of Effect of GOL by Catalase-Latex 
Injection*  Days survival (mean +  SEM) 
Salines  10.6 +  0.5 
Catalase-latex§  10.4 ±  0.6 
GOLII  15.4 ±  2.0 
GOL +  catalase-latex  9.6 ±  0.2 
* Five mice per group were injected with 10  n P388 ceils i.p. plus the substances 
indicated. All mice received a total of 1 ml MEM and 1 ml saline. They were 
then placed in 100% 02 for 1 h and 49% 02 for 1 h. 
$ 0.9% NaCI. 
§ 5 ×  109 particles with a catalase activity equivalent to 7,430 Sigma units (see 
Materials and Methods). 
I[  1 ×  1011 particles generating  103  nmol H202/min  under assay conditions 
(see Materials and Methods). 
would be expected to break down H202, without affecting the consumption of glucose 
or production of acid by GOL, it appeared that H202 was necessary for the antitumor 
effect of GOL. 
Effect of GOL against  Lower Doses of P388 i.p.  No mice were cured by GOL after 
being injected with  106 P388 cells i.p. However, injection of 1 ml GOL led to long- 
term survival of increasing proportions of mice injected with fewer P388 cells. Two 
such experiments, with observation periods in excess of 441 and 303 d, are illustrated 
in Fig. 3. GOL appeared to cure 23% of the mice after injection of 105 P388 ceils, 77% 
after 104 cells, and 92% after 103 cells. Boiled GOL cured no mice, even when only 103 
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Fro.  3.  Survival of mice injected with the indicated numbers of P388 cells i.p. followed by 1 ml of 
the following: GOL (glucose oxidase-latex), BGOL (boiled GOL), NS (normal saline), or SGO (soluble 
glucose oxidase,  5  Sigma  units).  There  were  seven  mice  per  group  followed  for  441  d  in  the 
experiment shown in A, and 6 mice per group followed for 303 d in B. 1546  ANTITUMOR  EFFECTS  OF  HYDROGEN  PEROXIDE  IN  VIVO 
equivalent to 3 ml of GOL, cured none of the mice injected with as few at  104 P388 
cells (Fig. 3), nor even prolonged their survival (15.5  ±  0.4 d, compared with  15.3 ± 
0.8 d for mice given saline). 
Effect  of GOL against  s.c. P388.  When  injected s.c.,  P388  grows  as a  nodule and 
metastasizes  (unpublished observations). As few as  103 P388 cells s.c.  killed three of 
three mice,  102 cells s.c. killed two of three mice, and  10 cells s.c. killed one of three 
mice. As shown in Fig. 4, when  10  ~ P388 cells were admixed with 0.03 ml of saline 
and  injected  s.c.,  the  tumors  grew  slowly  for  4  d  and  then  expanded  rapidly  to 
diameters as great as 2,5 cm, killing six of six mice at  15.7 ±  0.5 d. Admixture of 0.03 
ml of boiled GOL (3.9 ×  10  s particles) delayed the onset of the rapid growth phase by 
8  d, but  thereafter the nodules grew as fast as in the saline controls, killing all the 
mice at  23.3  :l:  2.8  d.  In  contrast, injection of the same number of GOL particles 
together with P388 cells completely suppressed nodule formation in five of six mice. 
Glucose  was  not  present  in  the  syringe  containing  GOL  and  tumor  cells,  so  the 
antitumor effect seen with GOL and not with boiled GOL presumably commenced 
after  injection.  Nonetheless,  three  of the  mice  without  local  nodules  died  from 
metastases. When the number of beads was tripled, boiled GOL also began to suppress 
nodule formation (data not shown). 
Effect of GOL against a Peroxide-resistant Tumor." Synergy with BCNU.  P815 mastocy- 
toma cells require ,,,4.2  times more glucose oxidase to lyse 50% of the cells than do 
P388 lymphoma cells (19).  1 ml of GOL did not prolong the survival of mice injected 
with  106  P815  cells  i.p.,  whether  or  not  the  mice  received supplemental  02  (not 
shown). However, in vitro, it is possible to increase the susceptibility of P815 cells to 
lysis by glucose oxidase by an average of 5.5-fold by exposing the cells to BCNU (19). 
This effect of BCNU  appears  to be due to its  inhibition of tumor cell glutathione 
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FIG. 4.  Growth of nodules of P388  lymphoma after s.c. injection of l0  s cells  mixed with normal 
saline, GOL, or boiled GOL. Means for six  mice per group. In the GOL group, only one mouse 
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Fla.  5.  Effect  of dose of BCNU injected i.p. on the survival (&) of normal mice (numbers of mice 
indicated in parentheses) or the activity of glutathione reductase (O) in P815 ascites cells. 
reductase  (19).  Accordingly, we determined  the  dose of BCNU necessary to inhibit 
glutathione  reductase  in  P815  ascites  cells  in  vivo  (Fig.  5).  30  mg  BCNU/kg,  the 
highest  nonlethal  dose tested  (Fig.  5),  inhibited  glutathione  reductase >80%.  In the 
experiment  shown in Table V, this dose of BCNU alone led to long-term survival in 
only 15%  (2 of 14)  mice given  106 P815 cells i.p. COL alone cured none of the mice. 
However,  the  combination  of BCNU  and  GOL  produced  86%  (6  of 7)  long-term 
survivors (>422 d).  No such synergistic effect was seen with boiled GOL  (Table V). 
The combination of BCNU and GOL was not tested against P388 lymphoma, because 
BCNU  alone  produced  100%  long-term  survivors  when  given  after  as  many as  107 
P388 cells (not shown). 
Toxicity of GOL.  Mice injected with  1 ml GOL i.p. appeared  healthy throughout 
the period of observation  (up  to 441  d).  Among >300  mice injected  with  GOL, no 
deaths  could  be  attributed  to  this  agent.  Erythrocyte  counts  and  serum  levels  of 
glucose,  urea,  creatinine,  bilirubin,  glutamic-pyruvic  transaminase,  and  creatine 
phosphokinase  (CPK)  were measured before GOL and at  intervals  up to  1 wk after 
its injection  into mice exposed  to  100% 02  for 3.5 h. The results  are given in Table 
TABLE  V 
Synerg~ between BCNU and GOL against P815 Mastocytoma 
Latex injection*  BCNU:~  Survivors/total number 
of mice§ 
None  -  0/7 
+  2/7 
Boiled GOL  -  0/7 
+  O/7 
GOL  -  0/7 
+  6/7 
* 1 ml i.p. Mice not getting latex got 0.9% NaC1. 
:~ 30 mg/kg i.p. in 0.5 ml MEM-2% ethanol. Mice not getting BCNU got the 
vehicle alone. 
§ Survivors observed for 422 d. 1548  ANTITUMOR  EFFECTS OF HYDROGEN PEROXIDE IN VIVO 
VI. The blood tests remained normal, except for a single low erythrocyte count and 
elevated CPK values after the 8th hour. The results of complete autopsies performed 
up to 10 mo after injection of GOL were described above. 
Effect of Preformed He Oe and Organic Hydroperoxides.  30 mmol H202/kg i.p. was lethal 
within -30 s, probably because of the formation of O2 emboli after contact of H202 
with erythrocyte catalase (27,  28). After 10 mmol H202/kg i.p., mice looked severely 
ill, but  recovered. The latter dose of H202 extended the survival of mice given  106 
P388 cells immediately beforehand from  12.4 +  0.7 to  15.2 +  0.5 d. Mice given  106 
P815 cells i.p., followed by 10 mmol H202/kg i.p., lived no longer than controls given 
0.9% NaC1 alone. Ethylhydroperoxide and cumenehydroperoxide were injected i.p. in 
the expectation of avoiding gas formation. Both, however, were highly toxic, even at 
doses as low as 1 mmol/kg. 
Discussion 
It is of considerable interest to learn whether any proposed mediator of cytotoxicity 
can exert an antitumor effect in vivo. Possible obstacles to in vivo efficacy include the 
size of the anatomic compartments, the chemically reactive nature of the extracellular 
fluids, washout by the blood and lymph, metabolism by adjacent and distant tissues, 
and the intermingling of normal and neoplastic cells. 
Hydrogen peroxide contributes  to  the  lysis of tumor  cells  by macrophages  and 
granulocytes in a variety of experimental settings in vitro (2-13).x The studies reported 
here showed that H202 generated by a solid-phase enzyme can also kill tumor cells in 
vivo, in the peritoneal cavity, without harm to the host. 
To be effective, the enzyme that  generated H202 had  to be coupled to particles. 
Soluble glucose oxidase, given in maximum sublethal doses, did not kill an appreciable 
number of tumor cells, perhaps because it left the peritoneal cavity too quickly. A 
single injection of preformed H202 killed substantial  numbers of tumor cells in the 
peritoneal cavity, but only at doses nearly lethal to the mice. Organic hydroperoxides 
were even more toxic than H202. In contrast, glucose oxidase coupled to latex particles 
was able to destroy up to 99.6% of an i.p. inoculum of 106 P388 lymphoma cells, and 
100% of smaller inocula, without evident toxicity. 
TABLE VI 
Effect of GOL on Blood Tests 
Hours after  Erythrocytes/  Glucose  Urea nitrogen  Creatinine  Bilirubin  SGPT:~  CPK§ 
Injection*  injection  milliliter 
mg/  dl  mg/  dl  mg/  dl  rng  / dl  I "/  hter  ~ "/liter 
Saline[]  3.5  9.1  :t: 0.8 ×  109  17326  21.8+0.9  0.4+02  0.4±0.3  12.5-t-0.5  270±47 
GOL¶  3.5  7.1  X  10  a  161  27.7  0.5  0.fi  12.8  133 
GOI,  8  8.5 x  10  a  175  21.9  0.5  0.1  1 I.I  801 
GOL  23  7.8 ×  109  183  21.0  0.7  0.0  19.7  3,379 
GOL  47  I 1.1 ×  109  179  20.5  0.6  0.0  15.2  860 
GOL  170  6.6 X  109  207  21.2  0.8  0.0  15.8  3.591 
Reported  normal  10.1  X  109  174  NI):~  II  0.4  l0  23  262 
values** 
* Mice were injected with  I ml of the indicated material i.p. and then exposed to  100~7~ 0,2 for 3.5 h. 
* Serum glutamate-pyruvate  transamlnase. 
§ Creatine phosphokinase. 
I[ Means +  SEM for three mice. 
¶ Values from individual mice. 
** From reference 25. 
** Data not given. CARL F.  NATHAN AND ZANVIL A. COHN  1549 
That  the effects of GOL were mediated by H202 is supported by three lines of 
evidence:  increased  antitumor  activity  after augmenting  the  concentration  of the 
substrate, 02; abolition of the antitumor effect by boiling the GOL to inactivate the 
enzyme;  and  complete  protection of the  tumor  cells  by simultaneous  injection of 
catalase  coupled to  latex  particles. The  latter  result  militates  against  glucose con- 
sumption or acid production playing an important role in the antitumor action of 
GOL. 
The  possibility  remains  that  the  H202  produced  by GOL  elicits  inflammatory 
changes, which in turn suppress tumor growth. Two considerations make this unlikely. 
First is the minimal extent of inflammation detected histologically. From 3 to 20 h 
after injection, there was a scant neutrophilic exudate. After -3 h, the vast majority 
of beads came together in a limited number of tightly packed aggregates. During the 
first  week,  these  aggregates  were  infiltrated  by  macrophages,  which  ingested  the 
beads. Autopsies at intervals up to 10 mo after the injection of GOL revealed no other 
inflammatory changes. Second, GOL exerted an antitumor effect for up to 1 h after 
its injection, but not thereafter. As noted, cellular inflammatory changes only became 
detectable later. 
In contrast to the results with P388 lymphoma, GOL alone was ineffective against 
P815 mastocytoma, a  more peroxide-resistant tumor (19). In vitro, BCNU inhibited 
glutathione  reductase  in  P815  cells  and  thereby sensitized  them  to  lysis by  H202 
generated by glucose oxidase (19).  Doses of BCNU well tolerated by the mice also 
inhibited P815 cell glutathione reductase in vivo. As predicted, the combination of 
GOL and BCNU apparently cured mice given  106 P815 cells i.p. However, proof is 
lacking that  the synergistic interaction between GOL and  BCNU  in  vivo had  the 
same basis as that observed in vitro. 
Supplemental 02, but not glucose, enhanced the antitumor effect of GOL. In mouse 
arterial blood, the concentrations of 02 and glucose are normally ~0.14 and 9.6 mM, 
respectively (25).  In  the peritoneal cavity, the 02 concentration is  lower, probably 
-0.06 mM (26). With GOL, we observed a Km for oxygen of 0.01  mM and a Km for 
glucose of 16.7 mM. However, these values, or the wide-ranging values reported from 
experiments in which soluble glucose oxidase was used (20, 22-24), may be misleading 
under the conditions prevailing in the peritoneal cavity after the injection of GOL. 
For example, assuming no replenishment, GOL would be calculated to exhaust the 
content of O2 in the injected fluid in -3 min. In that time, the glucose content in the 
same fluid would be expected to have diminished by only 9%. Thus, regardless of the 
Kms,  it  is  plausible  that  02  rather  than  glucose  would  be  rate  limiting  for  the 
production  of H202  by  GOL  in  the  peritoneal  cavity.  The  actual  rate  of H202 
production by GOL in vivo was not  determined, but presumably was  much lower 
than that measured under standard assay conditions in vitro (Table I). 
GOL did  not  appear  to be  toxic to  mice  observed  for about  half their normal 
lifespan, as judged by their appearance and by complete post-mortem examinations. 
For up to 1 wk after injection of GOL, normal values were recorded for the erythrocyte 
count, blood glucose, and tests of function of the kidneys and liver. However, CPK 
was  elevated  in  most  of the  samples  assayed.  It  is  doubtful  that  this  elevation  is 
significant,  inasmuch  as  histologic changes  were  not  noted  in  the  heart,  brain,  or 
skeletal  muscle,  the  usual  sources of clinically  significant  serum  concentrations of 1550  ANTITUMOR  EFFECTS OF HYDROGEN PEROXIDE IN VIVO 
CPK. Trauma to muscle may have released CPK into the wound during collection of 
blood samples from the axillary vessels, giving artifactual elevations. 
The basis for the apparently selective toxicity of GOL toward  tumor cells rather 
than normal host tissues is not known. Various cells differ markedly in their suscep- 
tibility or resistance to H202 (2,  17,  19). It has not been determined whether the cells 
comprising the  intraabdominal  tissues  are  more resistant  to  H202  than  the  tumor 
cells used in these experiments. It is possible that normal cells are protected against 
H202 not only by intrinsic antioxidant defenses but also by washout and catabolism 
of H202 in the circulation by which they are served. 
In  the  National  Cancer  Institute's  prescreening  program  for new  drugs,  CD2F1 
mice are given  106 P388 cells i.p., followed by five daily injections of the agent under 
study.  A  trial  is considered positive if survival is prolonged 20%. 3 In this report, we 
administered  GOL  or  H202  only  once  per  mouse.  It  would  be  of interest  to  test 
multiple injections of these agents, and to investigate possible enhancement of their 
effects by peroxidases and by inhibitors of H2Oe catabolism other than BCNU. 
Over the past  30 yr, there have been numerous  attempts to treat tumor-bearing 
patients or animals with H202.  As a  single agent, preformed H202 has usually been 
ineffective when injected  into a  solid tumor or into the circulation  (29-35).  On  the 
other hand, animals with malignant ascites were said to survive longer than controls 
after injection of H202 into the peritoneal cavity (33,  36, 37). Unfortunately, none of 
the latter studies presented full data on this point. 
In  1920,  Oliver and Murphy (27)  gave H202 by vein to patients who appeared to 
be  dying  of pneumonia  in  an  attempt  to  generate  oxygen  through  the  catalatic 
decomposition of H202 in  the bloodstream. The dramatic recovery of some of their 
patients encouraged other investigators to use parenteral H202 to increase the oxygen 
tension  in tumors during radiotherapy  (29,  32,  38-41)  or chemotherapy (34,  35,  37, 
38).  Enhancement of the effect of radiotherapy or chemotherapy was usually claimed, 
although none of the clinical trials and few of the studies in animals were adequately 
controlled.  In one well-designed  study,  radiation  therapy was  more effective when 
H202  was  given  intravenously  20  s  before  but  not  when  given  5  min  before  or 
immediately after irradiation  (29).  Such  results strongly suggested that  H202 acted 
by  enhancing  the  oxygen  effect  of radiation  rather  than  by  injuring  tumor  cells 
directly  (29).  Enhanced  oxygenation has also been invoked to explain  the enhance- 
ment of chemotherapy by H202 (35). 
The antitumor effects of H202 generated by glucose oxidase cannot be attributed 
to enhanced tumor oxygenation because glucose oxidase consumes more oxygen than 
catalase releases. 4 To our knowledge, the only previous report on the administration 
of glucose oxidase to tumor-bearing animals involved a single, incompletely controlled 
experiment in which the glucose oxidase was mixed with catalase (42).  Prolongation 
of survival of the treated animals was attributed to glucose consumption (42). 
Thus, we believe that  ours is the first report  to establish convincingly that  H202 
can exert  a  direct  antitumor effect in  vivo and  thereby prolong the survival of the 
host.  Injection of solid-phase glucose oxidase into the tumor bed was not associated 
with  significant  toxicity  by  the  criteria  employed.  Finally,  we  extended  earlier 
Abbott, B., Division of Cancer Treatment, National Cancer Institute. Personal communication. 
4  Glucose + O2  glucose  oxidase  eatalase  ~, gluconic acid + H202; H202  ~ H20 + 1/2 02. CARL F.  NATHAN AND ZANVIL A. COHN  1551 
observations (35,  37)  that H202 can synergize in vivo with certain antitumor drugs 
already  in  clinical  use.  These  findings  help  lay  the  groundwork  for experimental 
therapies based on oxidative injury of tumor cells. 
Summary 
Glucose oxidase, covalently coupled to polystyrene microspheres (GOL), produced 
H202  at  an  average  rate  of 3.6  nmol/min  per  109  beads  under  standard  assay 
conditions. Injection of 1.3 ×  101° to  1.1  ×  10  ix GOL i.p. prolonged the survival of 
mice by 27% after injection of 106 P388 lymphoma cells in the same site, consistent 
with destruction of 97.6% of the tumor cells.  Placing mice for several hours in  100% 
O~,  the  probable rate-limiting substrate  for GOL, afforded a  42%  prolongation of 
survival from P388 lymphoma, consistent with destruction of 99.6% of the tumor cells. 
When the P388 inoculum was  105, 104, or  10  a cells, GOL led to long-term survival 
(presumed  cure)  of 23%,  77%,  and  92%  of the  mice,  respectively, consistent  with 
reduction of the injected tumor dose to <10 cells.  Subcutaneous growth of 105 P388 
cells (~300 lethal dose to 50% of mice) was suppressed in 83% of mice by admixture 
of GOL with  the  tumor cell  inoculum.  GOL alone  had  no  effect against  a  more 
peroxide-resistant tumor, P815 mastocytoma. However, P815 cell glutathione reduc- 
tase could be inhibited in vivo by well-tolerated doses of the antitumor agent,  1,3- 
bis(2-chloroethyl)-l-nitrosourea (BCNU).  BCNU  alone cured  few mice with  P815. 
Together, BCNU  and GOL apparently cured 86% of mice injected with  106 P815 
cells i.p. The protective effect of GOL was abolished by boiling it to inactivate the 
enzyme, by co-injection of catalase coupled to latex beads, or by delaying the injection 
of tumor cells for 3 h, by which time the beads had formed aggregates. Soluble glucose 
oxidase,  in  doses  threefold  higher  than  that  bound  to  GOL,  had  no  detectable 
antitumor effect. A single injection of preformed H202 readily killed P388 cells in the 
peritoneal cavity, but only at doses nearly lethal to the mice. In contrast, GOL had 
very little toxicity, as judged by the normal appearance of the mice for over 400 d, 
gross and microscopic findings at autopsy, and various blood tests. GOL injected i.p. 
remained in the peritoneal cavity, where it was gradually organized into granulomata 
by macrophages, without generalized inflammation. Thus, an H202-generating system 
confined to the tumor bed exerted clear-cut antitumor effects with little toxicity to 
the host. 
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Walberg in performing autopsy studies. We also thank B. Arrick and A. Szuro-Sudol  for help 
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